Journal

PassMedicine can carry UKMLA AKT volume, but its dashboard optimises practice statistics, not content-map coverage — here is what each number means, where selection bias hides, and...

Pastest brings an AI assistant to MSRA revision — here is the reproducible rubric for testing what it grounds and where it guesses, why the Professional Dilemmas paper is beyond it...

PassMedicine can drill MSRA clinical knowledge at scale, but its dashboard cannot see half the exam — this audit explains what each metric measures, why repeats flatter you, and ho...

Pastest's Tutor mode puts an AI assistant inside MRCP Part 1 practice — this audit gives you the six-question rubric, provenance checks and safe-use protocol to find out what it gr...

PassMedicine's MRCP Part 1 dashboard optimises practice performance, not exam readiness — here is what each metric really measures, where selection bias hides, and how to audit you...

AMBOSS's chart-to-knowledge roadmap is a genuinely useful model to learn from. Building the NHS equivalent is not a translation exercise. It changes the source hierarchy, the techn...

AMBOSS and UpToDate have already been compared on general merit elsewhere. The genuinely new question in 2026 is which one is winning the race to actually live inside the clinical ...

AMBOSS and ClinicalKey AI are approaching the same destination, evidence embedded directly in the EHR, from genuinely different starting points. One is racing to build patient-cont...

A Stanford-Harvard evaluation using 100 real clinical cases ranked AMBOSS AI Mode first for safety among 31 systems tested. This is a genuinely more informative benchmark than an e...

FHIR and MCP solve genuinely different problems and are easy to conflate. One moves patient data between systems. The other lets an AI agent reach external knowledge and tools. Nei...

AMBOSS says its healthcare integrations are built on FHIR, the standard that lets different health record systems actually talk to each other. Here is what that means in plain term...

AMBOSS's clinical search agent takes a deliberately narrow, curated approach to sourcing. A full review of what it does well, where it falls short, and how it compares to a UK-nati...